Ben focuses his practice on regulatory compliance, internal and government investigations and enforcement matters affecting clients across the health care industry. With nearly 20 years of experience in both government and private practice, Ben brings insight into federal enforcement strategy and a deep understanding of the compliance risks faced by health care entities, including providers, pharmaceutical and medical device companies, clinical laboratories and others.  

Prior to joining Polsinelli, Ben served in the Office of Inspector General (OIG) at the U.S. Department of Health and Human Services (HHS), where he held roles in both the Industry Guidance Branch and the Administrative and Civil Remedies Branch. Over almost six years at OIG, Ben provided legal analysis and advice on key fraud and abuse laws impacting the health care industry, including the Federal Anti-Kickback Statute, the Physician Self-Referral Law and the False Claims Act. Ben authored and contributed to numerous advisory opinions, industry guidance documents, policy statements and other interpretive guidance. He also was a member of the team that authored new Anti-Kickback Statute safe harbor regulations issued as part of the Regulatory Sprint to Coordinated Care. In addition, Ben worked closely with the Department of Justice (DOJ) to investigate and evaluate a wide variety of health care fraud cases. He also negotiated OIG integrity obligations as part of False Claims Act settlements and resolved self-disclosures submitted under OIG’s Health Care Fraud Self-Disclosure Protocol.

Prior to his government service, Ben spent more than a decade in private practice, representing health care clients in internal investigations, False Claims Act litigation and regulatory compliance matters. Before attending law school, Ben represented health care clients in public policy matters before Congress and Federal agencies, including as policy director of a trade association for medical device manufacturers.

Education

  • The University of Texas at Austin School of Law (J.D., with honors)
    • Texas Law Review, Articles Editor
    • Order of the Coif
  • University of Pennsylvania (B.A.)

    Bar Admission

    • Colorado
    • District of Columbia

    Court Admissions

    • U.S. District Court for the District of Columbia
    • U.S. District Court, Western District of Texas
    • U.S. District Court, Southern District of Texas
    • U.S. Court of Appeals, Fifth Circuit
    • U.S. Court of Appeals, Federal Circuit

    Professional Affiliations

    • American Health Law Association
      • Vice Chair of Fraud and Abuse Practice Group, 2027
    • American Bar Association, Health Law Section
    • Health Care Compliance Association

    Recognition

    • Inspector General’s Cooperative Achievement Award, 2021 and 2023
    • Secretary’s Award for Meritorious Service, 2021           
    • Inspector General’s Award for Excellence in Fighting Fraud, Waste, and Abuse, 2021
    • Inspector General’s Award for Excellence in Promoting Quality, Safety, and Value, 2021
    • Inspector General’s Award for Advancing Excellence and Innovation, 2021
    • CIGIE Award for Excellence, Law and Legislation, 2021
       

    Clerkships

    • Judicial Clerkship: The Honorable Edward C. Prado, U.S. Court of Appeals for the Fifth Circuit
    Publications
    Fraud & Abuse: Recent Trends, Key Developments and What's Next
    Polsinelli proudly introduces its Fraud and Abuse: Recent Trends, Key Developments and What’s Next e-book. This publication is intended to serve as a valuable resource for health care industry stakeholders, aiming to equip you with insight into the past year’s happenings in order to better navigate the complex landscape of health care fraud and abuse enforcement. Drawing upon the decades of experience that Polsinelli’s government investigations team has in defending False Claims Act cases and health care government investigations, we curated the most notable settlements, court decisions and guidance from regulators in 2025.
    Read More
    CMS Announces Wide-Ranging Fraud Crackdown
    Key Takeaways: Centers for Medicare & Medicaid Services (CMS) deferred $259.5 million in federal Medicaid funds to Minnesota over program integrity concerns. CMS will impose a six-month nationwide moratorium on new enrollments for certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) suppliers. CMS issued a Request for Information seeking stakeholder feedback under its CRUSH initiative to strengthen and expand fraud prevention tools, signaling a wide range of possible new anti-fraud measures. On Feb. 25, 2026, Vice President J.D. Vance, HHS Secretary Robert F. Kennedy, Jr. and CMS Administrator Dr. Mehmet Oz announced a series of actions aimed at strengthening program integrity across Medicare and Medicaid. The Administration characterized the initiative as part of a broader affordability strategy focused on preventing fraud, waste and
    Read More